United Therapeutics (UTHR) Net Shares Issued and Repurchased (2011 - 2020)

United Therapeutics has disclosed Net Shares Issued and Repurchased across 10 years of filings, most recently posting $5875.0 for Q1 2020.

• In Q1 2020, Net Shares Issued and Repurchased fell 92.39% year-over-year to $5875.0; the TTM figure through Mar 2020 stood at $5875.0 (down 92.39% YoY), while the FY2019 annual figure was $100662.0, down 89.9% from the prior year.
• Net Shares Issued and Repurchased came in at $5875.0 for Q1 2020 at United Therapeutics, down from $100662.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.0 million in Q4 2017 to a low of $5875.0 in Q1 2020.
• Average Net Shares Issued and Repurchased over 5 years is $802442.9, with a median of $591713.0 recorded in 2016.
• Year-over-year, Net Shares Issued and Repurchased surged 3851.94% in 2016 and sank 95.58% in 2018.
• Over 5 years, Net Shares Issued and Repurchased stood at $591713.0 in 2016, then soared by 231.05% to $2.0 million in 2017, then tumbled by 49.11% to $996775.0 in 2018, then plunged by 89.9% to $100662.0 in 2019, then plunged by 94.16% to $5875.0 in 2020.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $5875.0 in Q1 2020, $100662.0 in Q4 2019, and $77200.0 in Q1 2019.